Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| FEDERAL MOGU | FDML | 7.11% |
| SCIENTIFIC L | SCIL | 6.67% |
| RADIANT LOGI | RLGT | 4.26% |
| NATUS MEDICA | BABY | 3.86% |
| NEW ORIENTAL | EDU | 3.58% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
EnterpriseProducts Partners L.P.(EPD">EPD) and Genesis Energy L.P. ( GEL - Snapshot Report ) have inked a construction agreement for a crude oil gathering pipeline to serve the Lucius development area in the Gulf of Mexico.
Southeast Keathley Canyon Pipeline Company LLC (“SEKCO”) - a 50:50 joint venture between Enterpriseand Genesis, will be the owner and responsible for the construction.
Enterprise and Genesis have executed the crude oil transportation agreement with a group of six producer companies consisting of Anadarko Petroleum Corporation ( APC - Analyst Report ) , Apache Corp. ( APA - Analyst Report ) , ExxonMobil Corp. ( XOM - Analyst Report ) , Eni SpA ( E - Analyst Report ) , Petroleo Brasileiro (PBR), and Plains Exploration & Production Company (PXP).
The 149-mile SEKCO pipeline, capable of carrying 115,000 barrels per day (bpd), will link the Lucius-truss spar floating production platform to an existing junction platform at South Marsh Island 205 that forms part of the Enterprise-operated Poseidon pipeline system.
The SEKCO pipeline is expected to come online by mid-2014. It will also provide a reliable source of uninterrupted crude oil supplies to Gulf Coast refineries. The Lucius production area is estimated to contain reserves in excess of 300 million barrels of oil equivalent.
Enterprise with a 36% stake is the operator of the Poseidon pipeline system, which has a capacity to carry around 400,000 barrels per day of crude oil.
We continue to view Enterprise Products Partners as a core holding in an MLP portfolio, given its string of organic growth projects, potential acquisitions, strong balance sheet and solid liquidity position. The partnership is one of the largest fully integrated midstream service providers with a positive long-term outlook given its significant geographic and business diversity.
Enterprise holds a Zacks #3 Rank, which is equivalent to a Hold rating for a period of one to three months. We maintain an Outperform rating on the stock for the long term.
Read the full Analyst Report on EPD
Read the full Analyst Report on APA
Read the full Analyst Report on E
Read the full Analyst Report on XOM
Read the full Analyst Report on APC
Read the full Snapshot Report on GEL